retinol has been researched along with lovastatin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bilodeau, M; Cianflone, K; Davignon, J; Sniderman, AD | 1 |
| Adams, SE; Bishop, EJ; Melnykovych, G | 1 |
| Blomhoff, R; Carlander, B; Norum, KR; Wathne, KO | 1 |
| Iwasaki, T; Kato, S; Sasaki, H; Tada, N | 1 |
| Gylling, H; Miettinen, TA; Relas, H | 1 |
| Assadollahi, F; Beaumont, JL; Buxtorf, JC; Cavallero, E; Jacotot, B | 1 |
| Anthony, M; Folkers, K; Loop, RA; Willis, RA | 1 |
| Connelly, PW; Hegele, RA; Jenkins, DJ; Little, JA; Maguire, GF; Tu, L; Vezina, C; Wolever, TS | 1 |
| Cabezas, MC; de Bruin, TW; Erkelens, DW; Jansen, H; Kock, LA; Kortlandt, W; Van Linde-Sibenius Trip, M | 1 |
| Sinzinger, H | 1 |
| Bok, SH; Choi, MS; Jang, MK; Jeon, SM; Lee, MK; Nam, KT; Park, YB; Rhee, SJ | 1 |
| Engel, E; Fröhlich, E; Wahl, R | 1 |
1 review(s) available for retinol and lovastatin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for retinol and lovastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor.
Topics: Apolipoproteins B; Cholesterol; Chylomicrons; Dietary Fats; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lipoproteins, LDL; Liver; Lovastatin; Male; Middle Aged; Oleic Acid; Oleic Acids; Time Factors; Triglycerides; Vitamin A | 1990 |
Elevation of alkaline phosphatase by retinol in bovine endothelial cells and its possible relationship to lipid biosynthesis.
Topics: Alkaline Phosphatase; Animals; Aorta; Cattle; Cells, Cultured; Cholesterol; Dexamethasone; Drug Synergism; Endothelium; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Synthase; Lipids; Lovastatin; Naphthalenes; Phosphatidylcholines; Tunicamycin; Vitamin A | 1986 |
Uptake of retinyl ester in HL-60 cells via the low-density-lipoprotein-receptor pathway.
Topics: Cell Line; Diterpenes; Humans; Leukemia, Promyelocytic, Acute; Lipoproteins; Lipoproteins, LDL; Lovastatin; Retinoids; Retinol-Binding Proteins; Retinyl Esters; Sterol O-Acyltransferase; Tumor Cells, Cultured; Vitamin A | 1989 |
High retinol/retinol-binding protein ratio in noninsulin-dependent diabetes mellitus.
Topics: Anticholesteremic Agents; Antioxidants; Apolipoprotein C-II; Apolipoprotein C-III; Apolipoproteins C; beta Carotene; Blood Glucose; Carotenoids; Cholesterol; Diabetes Mellitus, Type 2; Diterpenes; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Retinol-Binding Proteins; Retinyl Esters; Sex Characteristics; Simvastatin; Triglycerides; Vitamin A | 1995 |
Postprandial vitamin A and squalene clearances and cholesterol synthesis off and on lovastatin treatment in type III hyperlipoproteinemia.
Topics: Adult; Apolipoprotein E3; Apolipoproteins E; Cholesterol; Cholesterol, Dietary; Cohort Studies; Dietary Fats; Eating; Female; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lovastatin; Male; Metabolic Clearance Rate; Middle Aged; Phenotype; Reference Values; Squalene; Sterols; Triglycerides; Vitamin A | 1995 |
Familial xanthomatous hypercholesterolemia: abnormal exogenous lipid metabolism evidenced by the vitamin A test.
Topics: Adult; Apolipoproteins B; Eating; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipid Metabolism; Lipids; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides; Vitamin A; Wolman Disease | 1994 |
Effects of ethanol, lovastatin and coenzyme Q10 treatment on antioxidants and TBA reactive material in liver of rats.
Topics: Animals; Antioxidants; Body Weight; Coenzymes; Diet; Diterpenes; Drug Evaluation, Preclinical; Ethanol; Liver; Liver Diseases, Alcoholic; Lovastatin; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Retinyl Esters; Thiobarbituric Acid Reactive Substances; Ubiquinone; Vitamin A; Vitamin E | 1994 |
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics.
Topics: Adult; Aged; Chylomicrons; Diterpenes; DNA; Female; Genetic Variation; Genotype; Haplotypes; Heart Diseases; Humans; In Situ Hybridization; Lipase; Lipoproteins; Liver; Lovastatin; Male; Middle Aged; Molecular Biology; Pedigree; Phenotype; Retinyl Esters; RNA, Messenger; Vitamin A | 1993 |
Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.
Topics: Adult; Aged; Apolipoprotein C-II; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Cholesterol; Cholesterol, VLDL; Chylomicrons; Diterpenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Lipoprotein Lipase; Lovastatin; Middle Aged; Retinyl Esters; Simvastatin; Triglycerides; Vitamin A | 1993 |
Does vitamin E beneficially affect muscle pains during HMG-Co-enzyme-A-reductase inhibitors without CK-elevation?
Topics: Creatine Kinase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Muscle, Skeletal; Pain; Pain Measurement; Treatment Outcome; Vitamin A | 2000 |
Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Body Weight; Catalase; Cholesterol, Dietary; Cytosol; Diet, Atherogenic; Flavanones; Flavonoids; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Hydrogen Peroxide; Lipid Peroxidation; Lipid Peroxides; Liver; Lovastatin; Male; Mitochondria, Liver; Organ Size; Rabbits; RNA, Messenger; Superoxide Dismutase; Vitamin A; Vitamin E | 2001 |
Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Dipeptidyl Peptidase 4; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lovastatin; Thyroid Neoplasms; Vitamin A | 2011 |